DIAPHRAGMATIC STRENGTHENING EXERCISES FOR PATIENTS WITH POST COVID-19 CONDITION AFTER MILD-TO-MODERATE ACUTE COVID-19 INFECTION: A RANDOMIZED CONTROLLED STUDY

被引:0
|
作者
Abo Elyazed, Tamer I. [1 ]
Abd El Moneim Abd El Hakim, Ahmed [2 ]
Saleh, Ola I. [3 ]
Mostafa Fadel Sonbol, Marwa [3 ]
Eid, Hoda Assad [4 ]
Moazen, Eman M. [4 ]
Alhassoon, Mohammad Hamad [5 ]
Ezzat Fathy Elfeky, Seham [6 ]
机构
[1] Beni Suef Univ, Fac Phys Therapy, Phys Therapy Internal Med Dept, Ben Suef, Egypt
[2] Beni Suef Univ, Fac Phys Therapy, Basic Sci Dept, Ben Suef, Egypt
[3] Al Azhar Univ, Diagnost Radiol Dept, Cairo, Egypt
[4] Al Azhar Univ, Chest Dis Dept, Cairo, Egypt
[5] King Fahd Specialist Hosp, Internal Med Dept, Burydah, Saudi Arabia
[6] Tanta Univ, Chest Dis Dept, Tanta, Egypt
关键词
post COVID-19 condition; incentive spirometry; deep breathing; RESPIRATORY MUSCLE STRENGTH; INCENTIVE SPIROMETRY; PULMONARY-FUNCTION; QUALITY; DYSPNEA;
D O I
10.2340/jrm.v56.25491
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To assess the clinical effects of incentive spirometry (IS) and diaphragmatic breathing (DB) in patients with post COVID-19 condition and diaphragmatic dysfunction as compared with the standard care alone. Methods: The present longitudinal randomized study included 60 patients with post COVID-19 condition and diaphragmatic dysfunction. Patients were equally randomized to receive standard care plus IS (G1), standard care plus DB (G2) or standard care alone (G3) for 8 weeks. The primary outcome is clinical improvement as evaluated by the modified Medical Research Council (mMRC) dyspnoea scale. Results: Comparison between the studied groups revealed significant improvement in G1 and G2 in all parameters at the end of follow-up. However, no significant improvement was found in G3. At the end of follow-up, 15 patients (75.0%) in G1, 11 patients (55.0%) in G2, and 3 patients (15.0%) in G3 showed improvement on the mMRC dyspnoea scale. Multivariate logistic regression analysis identified mild acute COVID-19 infection ( p = 0.009), use of IS ( p < 0.001), and use of DB ( p = 0.023) as significant predictors of improvement on the mMRC dyspnoea scale. Conclusions: IS or DB training in addition to the standard care in post COVID-19 condition was associated with better clinical improvement as compared with the standard care alone.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Characteristics of Mild to Moderate COVID-19 Infection from an Urban Ambulatory COVID-19 Clinic - A Guide to Triage Patients in the Clinic
    Barbhaya, D. K.
    Franco, S.
    Gandhi, K. D.
    Arya, R.
    Neupane, R.
    Foroughi, N.
    Oluigbo, N.
    Fishbein, D.
    Tran, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [42] Thiol levels in mild or moderate COVID-19 patients: A comparison of variant and classic COVID-19 cases
    Dagcioglu, Basri Furkan
    Keskin, Ahmet
    Guner, Rahmet
    Kalem, Ayse Kaya
    Eser, Fatma
    Erel, Ozcan
    Neselioglu, Salim
    Bayrakdar, Fatma
    Ozkara, Adem
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [43] Myocardial Work Indices in Patients Recently Recovered from Mild-to-Moderate COVID-19
    Dankowski, Rafal
    Sacharczuk, Wioletta
    Fedorowicz, Julita
    Malek-Elikowska, Malgorzata
    Ozegowski, Stefan
    Baszko, Artur
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [44] Psychological rehabilitation for isolated patients with COVID-19 infection: A randomized controlled study
    Jung, Jae Hyu
    Won, Jong Jin
    Ko, Jin Young
    [J]. PLOS ONE, 2022, 17 (12):
  • [45] Mild Hyperglycaemia in Hospitalised Children with Moderate COVID-19 Infection
    Vojtkova, Jarmila
    Banovcin, Peter
    Durdikova, Anna
    Novakova, Elena
    Jesenak, Milos
    [J]. MEDICINA-LITHUANIA, 2023, 59 (05):
  • [46] Post-COVID symptoms and recovery times in hospitalized mild and moderate COVID-19 patients
    Khot, Rajashree
    Patil, Aastha
    Rathod, Bharatsing
    Kumbhalkar, Sunita D.
    Joshi, Prashant P.
    [J]. INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE, 2023, 9 (02) : 39 - 46
  • [48] Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study
    Jang, Young Rock
    Oh, Yoon Ju
    Kim, Jin Yong
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [49] Metabolic characteristics in patients with COVID-19 and no-COVID-19 interstitial pneumonia with mild-to-moderate symptoms and similar radiological severity
    Rizza, Stefano
    Nucera, Alessandro
    Chiocchi, Marcello
    Bellia, Alfonso
    Mereu, Daniele
    Ferrazza, Gianluigi
    Ballanti, Marta
    Davato, Francesca
    Di Cola, Giovanni
    Buonomo, Claudio O.
    Coppeta, Luca
    Vanni, Gianluca
    Gervasi, Romualdo
    Cardellini, Marina
    Lauro, Davide
    Federici, Massimo
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (11) : 3227 - 3235
  • [50] Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study
    Talebi, Seyed Saman
    Ghasemi, Mehran
    Etminani-Esfahani, Maryam
    Mohammadi, Younes
    Haddadi, Rasool
    [J]. PHARMACOLOGICAL REPORTS, 2022, 74 (06) : 1296 - 1305